• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency.一名具有极高突变等位基因频率的长期应答型表皮生长因子受体突变非小细胞肺癌患者。
Contemp Oncol (Pozn). 2022;26(1):88-89. doi: 10.5114/wo.2022.115447. Epub 2022 Mar 30.
2
Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review.表皮生长因子受体酪氨酸激酶抑制剂治疗前后表皮生长因子受体突变的非小细胞肺癌中的肿瘤免疫微环境：一篇叙述性综述
Transl Lung Cancer Res. 2021 Sep;10(9):3823-3839. doi: 10.21037/tlcr-21-572.
3
Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.表皮生长因子受体突变型非小细胞肺癌患者使用第一代表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）发生严重不良反应后切换使用第二代 EGFR-TKI 的临床影响。
Jpn J Clin Oncol. 2012 Jun;42(6):528-33. doi: 10.1093/jjco/hys042. Epub 2012 Mar 28.
4
High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.二氢嘧啶脱氢酶在肺腺癌中的高表达与表皮生长因子受体突变相关：对使用5-氟尿嘧啶治疗非小细胞肺癌的意义。
Clin Lung Cancer. 2014 Mar;15(2):136-144.e4. doi: 10.1016/j.cllc.2013.09.002. Epub 2013 Nov 14.
5
Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer.表皮生长因子信号调节表皮生长因子受体（EGFR）突变的非小细胞肺癌中双氢嘧啶脱氢酶的表达。
BMC Cancer. 2016 Jun 6;16:354. doi: 10.1186/s12885-016-2392-0.
6
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.厄洛替尼治疗的 EGFR 外显子 19 突变型非小细胞肺癌患者的异质性耐药机制：持续存在的 FGFR3 突变、局部转化为 EGFR 突变型小细胞肺癌，以及获得性 T790M EGFR 突变。
Lung Cancer. 2017 Nov;113:14-17. doi: 10.1016/j.lungcan.2017.08.024. Epub 2017 Sep 1.
7
Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District.悉尼西南部地方卫生区晚期表皮生长因子受体突变型非小细胞肺癌患者的临床结局
Intern Med J. 2017 Dec;47(12):1405-1411. doi: 10.1111/imj.13555.
8
Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer.易瑞沙，一种新型表皮生长因子受体酪氨酸激酶抑制剂，在 EGFR 突变型非小细胞肺癌中的作用。
Oncol Rep. 2012 Jun;27(6):2066-72. doi: 10.3892/or.2012.1741. Epub 2012 Mar 22.
9
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.低频率预处理 T790M 突变对接受 EGFR 酪氨酸激酶抑制剂治疗的 EGFR 突变型非小细胞肺癌患者的预测影响。
Lung Cancer. 2020 Jan;139:80-88. doi: 10.1016/j.lungcan.2019.10.029. Epub 2019 Nov 2.
10
Evaluation of epidermal growth factor receptor mutations and thyroid transcription factor-1 status in Turkish non-small cell lung carcinoma patients: A study of 600 cases from a single center.土耳其非小细胞肺癌患者表皮生长因子受体突变及甲状腺转录因子-1状态的评估：来自单一中心的600例病例研究
Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):143-150. doi: 10.5606/tgkdc.dergisi.2020.18196. eCollection 2020 Jan.

本文引用的文献

1
Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR.结直肠癌患者一线抗 EGFR 化疗后循环肿瘤 DNA 测序
Sci Rep. 2021 Aug 11;11(1):16333. doi: 10.1038/s41598-021-95345-4.
2
Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.NOIR-SS 与 ddPCR 检测晚期 L858R 阳性肺腺癌患者 EGFR L858R 基因突变的对比评估。
Sci Rep. 2021 Jul 22;11(1):14999. doi: 10.1038/s41598-021-94592-9.
3
Rare epidermal growth factor receptor gene alterations in non-small cell lung cancer patients, tyrosine kinase inhibitor response and outcome analysis.非小细胞肺癌患者中罕见的表皮生长因子受体基因突变、酪氨酸激酶抑制剂反应和预后分析。
Cancer Treat Res Commun. 2021;28:100398. doi: 10.1016/j.ctarc.2021.100398. Epub 2021 May 13.
4
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy.表皮生长因子受体（EGFR）突变的非小细胞肺癌（NSCLC）患者中变异等位基因频率对靶向治疗的影响
Front Oncol. 2021 Mar 30;11:644472. doi: 10.3389/fonc.2021.644472. eCollection 2021.
5
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon Mutations in Clinical Practice.在临床实践中治疗具有罕见突变的非小细胞肺癌患者。
Anticancer Res. 2020 Oct;40(10):5757-5764. doi: 10.21873/anticanres.14592.
6
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments.具有外显子 19 缺失或外显子 21 L858R 突变的非小细胞肺癌患者：不同的机制，对治疗的不同疗效。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2329-2338. doi: 10.1007/s00432-020-03296-6. Epub 2020 Jun 28.
7
Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.检测非小细胞肺癌患者中罕见和新型 EGFR 突变：对治疗决策的影响。
Lung Cancer. 2020 Jan;139:35-40. doi: 10.1016/j.lungcan.2019.10.030. Epub 2019 Nov 4.
8
Response and acquired resistance to savolitinib in a patient with pulmonary sarcomatoid carcinoma harboring exon 14 skipping mutation: a case report.一名患有携带第14外显子跳跃突变的肺肉瘤样癌患者对赛沃替尼的反应及获得性耐药：病例报告
Onco Targets Ther. 2019 Sep 6;12:7323-7328. doi: 10.2147/OTT.S210365. eCollection 2019.
9
Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.通过使用分子条形码对血浆DNA进行二代测序与生物信息变异过滤相结合的方法，对胰腺癌细胞中的体细胞突变进行选择性鉴定。
PLoS One. 2018 Feb 16;13(2):e0192611. doi: 10.1371/journal.pone.0192611. eCollection 2018.
10
High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients.使用条形码序列鉴定单个分子的高保真靶向测序：癌症患者血浆游离DNA中突变的从头检测和绝对定量。
DNA Res. 2015 Aug;22(4):269-77. doi: 10.1093/dnares/dsv010. Epub 2015 Jun 29.

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency.

作者信息

Miyazaki Kunihiko, Sato Yoshiharu, Satoh Hiroaki, Hizawa Nobuyuki

机构信息

Ryugasaki Saiseikai Hospital, Japan.

DNA Chip Research Inc., Tokyo, Japan.

出版信息

Contemp Oncol (Pozn). 2022;26(1):88-89. doi: 10.5114/wo.2022.115447. Epub 2022 Mar 30.

DOI:10.5114/wo.2022.115447
PMID:35506033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9052343/
Abstract
摘要